Sphera Funds Management LTD.
In its 13F for Q4 2025 (holdings as of December 31, 2025, filed February 17, 2026), Sphera Funds Management LTD. reported 94 stock positions worth $478.5 million. Its top holding was Teva Pharmaceutical-SP ADR (TEVA) at 7.3% of the portfolio, followed by Biogen (BIIB, 3.5%) and Mineralys Therapeutics (MLYS, 3.4%). Compared with Q3 2025, it opened 22 new positions, sold out of 29, added to 32 and reduced 25. The biggest buy was Cogent Biosciences (COGT, shares +284%) and the biggest sale an exit from Nice Ltd. - Spon ADR (NICE).
- Most Recent 13F
- Q2 2026
- Location
- TEL AVIV, L3
- CIK
- 0001496201
- Portfolio Value
- $478.5M (Q4 2025)
- SEC Filing
- 0001496201-26-000002 ↗ filed Feb 17, 2026
Holdings Value
Holdings 94 stocks · $478.5M
| TEVA Teva Pharmaceutical-SP ADR | 7.33% | 1,123,525 | $35.1M | Reduce -25.4% |
| BIIB Biogen Inc. | 3.48% | 94,738 | $16.7M | Add +14.5% |
| MLYS Mineralys Therapeutics Inc. | 3.41% | 449,003 | $16.3M | Add +104.2% |
| SNDX Syndax Pharmaceuticals Inc. | 3.35% | 762,563 | $16.0M | Add +96.7% |
| NVMI Nova Ltd. | 3.28% | 47,846 | $15.7M | Add +9.0% |
| TSEM Tower Semiconductor Ltd. | 3.01% | 122,513 | $14.4M | Reduce -60.7% |
| COGT Cogent Biosciences Inc. | 2.81% | 378,500 | $13.4M | Add +284.2% |
| AZN Astrazeneca PLC-Spons ADR | 2.59% | 135,060 | $12.4M | No change |
| SNY Sanofi-ADR | 2.43% | 239,515 | $11.6M | Add +9.1% |
| LLY Eli Lilly & Co. | 2.03% | 9,040 | $9.7M | Reduce -10.0% |
| FOLD Amicus Therapeutics Inc. | 1.96% | 658,377 | $9.4M | Reduce -33.6% |
| IMTX Immatics NV | 1.89% | 861,105 | $9.0M | Add +47.7% |
| BMRN Biomarin Pharmaceutical Inc. | 1.83% | 147,000 | $8.7M | New |
| BBIO Bridgebio Pharma Inc. | 1.72% | 107,746 | $8.2M | Add +164.4% |
| ORIC Oric Pharmaceuticals Inc. | 1.72% | 1,004,378 | $8.2M | Add +132.7% |
| DYN Dyne Therapeutics Inc. | 1.61% | 392,894 | $7.7M | Reduce -7.9% |
| TRVI Trevi Therapeutics Inc. | 1.57% | 598,534 | $7.5M | Reduce -7.0% |
| JNJ Johnson & Johnson | 1.55% | 35,831 | $7.4M | Reduce -12.3% |
| SVRA Savara Inc. | 1.48% | 1,178,164 | $7.1M | Reduce -12.8% |
| SRRK Scholar Rock Holding Corp. | 1.46% | 158,265 | $7.0M | New |
| WVE Wave Life Sciences Ltd. | 1.45% | 408,166 | $6.9M | Add +716.3% |
| RARE Ultragenyx Pharmaceutical Inc. | 1.44% | 300,623 | $6.9M | Reduce -14.7% |
| HELP Cybin Inc. | 1.41% | 825,576 | $6.8M | Add +122.9% |
| ANNX Annexon Inc. | 1.38% | 1,316,212 | $6.6M | Reduce -26.6% |
| BCRX Biocryst Pharmaceuticals Inc. | 1.37% | 837,889 | $6.5M | New |
| CLDX Celldex Therapeutics Inc. | 1.36% | 239,764 | $6.5M | Add +15.4% |
| SLNO Soleno Therapeutics Inc. | 1.32% | 136,314 | $6.3M | Add +227.6% |
| APLS Apellis Pharmaceuticals Inc. | 1.32% | 250,961 | $6.3M | Add +294.2% |
| GSK GSK PLC-Spon ADR | 1.25% | 122,000 | $6.0M | No change |
| ENPH Enphase Energy Inc. | 1.25% | 186,500 | $6.0M | Add +598.5% |
| NVO Novo-Nordisk A/S-Spons ADR | 1.23% | 115,677 | $5.9M | Add +9.5% |
| CYTK Cytokinetics Inc. | 1.22% | 91,717 | $5.8M | Reduce -43.2% |
| ABBV Abbvie Inc. | 1.21% | 25,256 | $5.8M | No change |
| SEDG Solaredge Technologies Inc. | 1.18% | 196,536 | $5.7M | Add +39.4% |
| ACAD Acadia Pharmaceuticals Inc. | 1.18% | 212,202 | $5.7M | Add +42.5% |
| VOR Vor Biopharma Inc. | 1.12% | 410,417 | $5.4M | New |
| MRK Merck & Co. Inc. | 1.07% | 48,600 | $5.1M | No change |
| NVS Novartis AG-Sponsored ADR | 1.07% | 37,000 | $5.1M | No change |
| FBRX Forte Biosciences Inc. | 1.06% | 185,869 | $5.1M | Reduce -60.8% |
| KOD Kodiak Sciences Inc. | 1.03% | 175,500 | $4.9M | New |
| TNGX Tango Therapeutics Inc. | 1.01% | 544,563 | $4.8M | New |
| SOLAR EDGE TECHNOLOGIES (SEDG 2.25 07/01/29) | 0.98% | 4,000,000 | $4.7M | No change |
| ATXS Astria Therapeutics Inc. | 0.97% | 355,725 | $4.7M | Add +41.6% |
| MDWD Mediwound Ltd. | 0.89% | 230,347 | $4.3M | Add +24.3% |
| CAMT Camtek Ltd. | 0.88% | 39,498 | $4.2M | Add +36.0% |
| RVMD Revolution Medicines Inc. | 0.87% | 52,500 | $4.2M | Reduce -12.5% |
| AMD Advanced Micro Devices | 0.81% | 18,040 | $3.9M | Add +16.6% |
| CLYM Climb Bio Inc. | 0.78% | 932,247 | $3.7M | Add +114.4% |
| ACOG Alpha Cognition Inc. | 0.77% | 567,616 | $3.7M | Add +67.6% |
| ELVN Enliven Therapeutics Inc. | 0.73% | 226,765 | $3.5M | Add +36.0% |
| TARA Protara Therapeutic Inc. | 0.72% | 650,000 | $3.5M | New |
| AVGO Broadcom Inc. | 0.71% | 9,755 | $3.4M | Add +48.8% |
| ELDN Eledon Pharmaceuticals Inc. | 0.67% | 2,132,131 | $3.2M | Add +66.5% |
| BIOA Bioage Labs Inc. | 0.67% | 243,035 | $3.2M | New |
| CRVS Corvus Pharmaceuticals Inc. | 0.66% | 407,709 | $3.1M | No change |
| ESLT Elbit Systems Ltd. | 0.64% | 5,340 | $3.1M | Reduce -20.8% |
| KURA Kura Oncology Inc. | 0.64% | 295,522 | $3.1M | Add +20.4% |
| MAZE Maze Therapeutics Inc. | 0.62% | 71,843 | $3.0M | Reduce -53.5% |
| ZIM Zim Integrated Shipping Serv | 0.60% | 136,005 | $2.9M | New |
| GPCR Structure Therapeutics Inc. | 0.60% | 41,000 | $2.9M | Reduce -76.4% |
| EVMN Evommune Inc. | 0.59% | 166,147 | $2.8M | New |
| VSTM Verastem Inc. | 0.55% | 343,678 | $2.7M | Add +338.9% |
| AMGN Amgen Inc. | 0.51% | 7,500 | $2.5M | Reduce -21.1% |
| NRIX Nurix Therapeutics Inc. | 0.49% | 124,000 | $2.4M | New |
| ASND Ascendis Pharma A/S | 0.49% | 11,000 | $2.3M | New |
| TENX Tenax Therapeutics Inc. | 0.48% | 190,111 | $2.3M | New |
| JANX Janux Therapeutics Inc. | 0.46% | 157,840 | $2.2M | Add +83.9% |
| PFE Pfizer Inc. | 0.45% | 86,000 | $2.1M | No change |
| TSHA Taysha Gene Therapies Inc. | 0.42% | 368,146 | $2.0M | Reduce -9.8% |
| CTNM Contineum Therapeutics Inc. Class A | 0.41% | 173,475 | $2.0M | New |
| MDGL Madrigal Pharmaceuticals Inc. | 0.40% | 3,300 | $1.9M | New |
| PHVS Pharvaris NV | 0.37% | 63,953 | $1.8M | Reduce -46.4% |
| VRNS Varonis Systems Inc. | 0.36% | 52,500 | $1.7M | Reduce -29.0% |
| DTIL Precision Biosciences Inc. | 0.34% | 396,116 | $1.6M | New |
| VTYX Ventyx Biosciences Inc. | 0.34% | 180,114 | $1.6M | Reduce -59.1% |
| IBIT iShares Bitcoin Trust ETF | 0.31% | 30,055 | $1.5M | Add +40.1% |
| DAWN Day One Biopharmaceuticals I | 0.28% | 145,371 | $1.4M | Reduce -17.1% |
| VYGR Voyager Therapeutics Inc. | 0.28% | 339,761 | $1.3M | Add +70.1% |
| TRDA Entrada Therapeutics Inc. | 0.24% | 110,942 | $1.1M | New |
| TNYA Tenaya Therapeutics Inc. | 0.22% | 1,500,000 | $1.1M | New |
| CATX Perspective Therapeutics Inc. | 0.20% | 349,973 | $962K | Reduce -31.4% |
| BMY Bristol-Myers Squibb Co. | 0.20% | 17,500 | $944K | No change |
| JSPR Jasper Therapeutics Inc. | 0.19% | 485,401 | $888K | Reduce -22.9% |
| PEPG Pepgen Inc. | 0.17% | 121,467 | $791K | Reduce -29.2% |
| STTK Shattuck Labs Inc. | 0.15% | 195,212 | $713K | New |
| PALI Palisade Bio Inc. | 0.09% | 184,100 | $433K | New |
| HOWL Werewolf Therapeutics Inc. | 0.08% | 626,810 | $397K | No change |
| SKYE Skye Bioscience Inc. | 0.07% | 478,928 | $359K | No change |
| PRLD Prelude Therapeutics Inc. | 0.07% | 122,752 | $356K | New |
| APRE Aprea Therapeutics Inc. | 0.05% | 270,000 | $230K | No change |
| OKUR Onkure Therapeutics Inc. Class A | 0.04% | 60,454 | $175K | No change |
| MREO Mereo Biopharma Group PL-ADR | 0.02% | 255,400 | $106K | New |
| PMN Promis Neurosciences Inc. | 0.02% | 11,807 | $81K | No change |
| APLT Applied Therapeutics Inc. | 0.00% | 50,000 | $5K | No change |
Options reported separately and not counted above: PRAX calls ($11.8M), XBI puts ($8.5M), RARE calls ($8.1M), NICE calls ($6.3M), TLT calls ($4.1M).
Portfolio Sells Q3 2025 → Q4 2025
| NICE Nice Ltd. - Spon ADR | Sold out | 0.00% | −5.41 |
| QQQ Invesco QQQ Trust Series 1 | Sold out | 0.00% | −3.27 |
| TSEM Tower Semiconductor Ltd. | Reduce -60.7% | 3.01% | −2.34 |
| CDTX Cidara Therapeutics Inc. | Sold out | 0.00% | −1.72 |
| CLBT Cellebrite Di Ltd. | Sold out | 0.00% | −1.31 |
| RAPP Rapport Therapeutics Inc. | Sold out | 0.00% | −1.11 |
| RARE Ultragenyx Pharmaceutical Inc. | Reduce -14.7% | 1.44% | −1.07 |
| IMVT Immunovant Inc. | Sold out | 0.00% | −0.98 |
| CYTK Cytokinetics Inc. | Reduce -43.2% | 1.22% | −0.89 |
| ENGN Engene Holdings Inc. | Sold out | 0.00% | −0.82 |
| RZLT Rezolute Inc. | Sold out | 0.00% | −0.81 |
| PRAX Praxis Precision Medicines I | Sold out | 0.00% | −0.73 |
| AMZN Amazon.com Inc. | Sold out | 0.00% | −0.72 |
| META Meta Platforms Inc. Class A | Sold out | 0.00% | −0.68 |
| ORA Ormat Technologies Inc. | Sold out | 0.00% | −0.66 |
| VRNS Varonis Systems Inc. | Reduce -29.0% | 0.36% | −0.65 |
| IDYA Ideaya Biosciences Inc. | Sold out | 0.00% | −0.65 |
| FBRX Forte Biosciences Inc. | Reduce -60.8% | 1.06% | −0.63 |
| GPCR Structure Therapeutics Inc. | Reduce -76.4% | 0.60% | −0.56 |
| CEVA Ceva Inc. | Sold out | 0.00% | −0.51 |
| TECX Tectonic Therapeutic Inc. | Sold out | 0.00% | −0.43 |
| PCVX Vaxcyte Inc. | Sold out | 0.00% | −0.43 |
| IMNM Immunome Inc. | Sold out | 0.00% | −0.41 |
| MIST Milestone Pharmaceuticals Inc. | Sold out | 0.00% | −0.39 |
| QURE Uniqure NV | Sold out | 0.00% | −0.34 |
| PHVS Pharvaris NV | Reduce -46.4% | 0.37% | −0.34 |
| MAZE Maze Therapeutics Inc. | Reduce -53.5% | 0.62% | −0.33 |
| BHVN Biohaven Ltd. | Sold out | 0.00% | −0.32 |
| BCAX Bicara Therapeutics Inc. | Sold out | 0.00% | −0.32 |
| SABS Sab Biotherapeutics Inc. | Sold out | 0.00% | −0.27 |
| JNJ Johnson & Johnson | Reduce -12.3% | 1.55% | −0.25 |
| CATX Perspective Therapeutics Inc. | Reduce -31.4% | 0.20% | −0.21 |
| LRMR Larimar Therapeutics Inc. | Sold out | 0.00% | −0.20 |
| ESLT Elbit Systems Ltd. | Reduce -20.8% | 0.64% | −0.17 |
| JSPR Jasper Therapeutics Inc. | Reduce -22.9% | 0.19% | −0.17 |
| ROIV Roivant Sciences Ltd. | Sold out | 0.00% | −0.15 |
| ETNB 89BIO Inc. | Sold out | 0.00% | −0.14 |
| AMGN Amgen Inc. | Reduce -21.1% | 0.51% | −0.12 |
| MLTX Moonlake Immunotherapeutics | Sold out | 0.00% | −0.12 |
| CMMB Chemomab Therapeutics Ltd. | Sold out | 0.00% | −0.11 |
| ARWR Arrowhead Pharmaceuticals Inc. | Sold out | 0.00% | −0.10 |
| DSGN Design Therapeutics Inc. | Sold out | 0.00% | −0.04 |
| PEPG Pepgen Inc. | Reduce -29.2% | 0.17% | −0.02 |
| DAWN Day One Biopharmaceuticals I | Reduce -17.1% | 0.28% | −0.01 |
| VTYX Ventyx Biosciences Inc. | Reduce -59.1% | 0.34% | +0.02 |
| ANNX Annexon Inc. | Reduce -26.6% | 1.38% | +0.08 |
| TSHA Taysha Gene Therapies Inc. | Reduce -9.8% | 0.42% | +0.11 |
| FOLD Amicus Therapeutics Inc. | Reduce -33.6% | 1.96% | +0.11 |
| TEVA Teva Pharmaceutical-SP ADR | Reduce -25.4% | 7.33% | +0.11 |
| TRVI Trevi Therapeutics Inc. | Reduce -7.0% | 1.57% | +0.17 |
Portfolio Buys Q3 2025 → Q4 2025
| COGT Cogent Biosciences Inc. | Add +284.2% | 2.81% | +2.47 |
| SNDX Syndax Pharmaceuticals Inc. | Add +96.7% | 3.35% | +1.93 |
| BMRN Biomarin Pharmaceutical Inc. | New | 1.83% | +1.83 |
| SRRK Scholar Rock Holding Corp. | New | 1.46% | +1.46 |
| MLYS Mineralys Therapeutics Inc. | Add +104.2% | 3.41% | +1.43 |
| BCRX Biocryst Pharmaceuticals Inc. | New | 1.37% | +1.37 |
| WVE Wave Life Sciences Ltd. | Add +716.3% | 1.45% | +1.36 |
| BBIO Bridgebio Pharma Inc. | Add +164.4% | 1.72% | +1.22 |
| VOR Vor Biopharma Inc. | New | 1.12% | +1.12 |
| KOD Kodiak Sciences Inc. | New | 1.03% | +1.03 |
| ENPH Enphase Energy Inc. | Add +598.5% | 1.25% | +1.02 |
| TNGX Tango Therapeutics Inc. | New | 1.01% | +1.01 |
| APLS Apellis Pharmaceuticals Inc. | Add +294.2% | 1.32% | +0.98 |
| HELP Cybin Inc. | Add +122.9% | 1.41% | +0.89 |
| BIIB Biogen Inc. | Add +14.5% | 3.48% | +0.74 |
| TARA Protara Therapeutic Inc. | New | 0.72% | +0.72 |
| IMTX Immatics NV | Add +47.7% | 1.89% | +0.71 |
| BIOA Bioage Labs Inc. | New | 0.67% | +0.67 |
| SLNO Soleno Therapeutics Inc. | Add +227.6% | 1.32% | +0.65 |
| ZIM Zim Integrated Shipping Serv | New | 0.60% | +0.60 |
| EVMN Evommune Inc. | New | 0.59% | +0.59 |
| CLYM Climb Bio Inc. | Add +114.4% | 0.78% | +0.57 |
| ATXS Astria Therapeutics Inc. | Add +41.6% | 0.97% | +0.54 |
| NRIX Nurix Therapeutics Inc. | New | 0.49% | +0.49 |
| ASND Ascendis Pharma A/S | New | 0.49% | +0.49 |
| ORIC Oric Pharmaceuticals Inc. | Add +132.7% | 1.72% | +0.49 |
| TENX Tenax Therapeutics Inc. | New | 0.48% | +0.48 |
| ACAD Acadia Pharmaceuticals Inc. | Add +42.5% | 1.18% | +0.43 |
| CTNM Contineum Therapeutics Inc. Class A | New | 0.41% | +0.41 |
| MDGL Madrigal Pharmaceuticals Inc. | New | 0.40% | +0.40 |
| VSTM Verastem Inc. | Add +338.9% | 0.55% | +0.39 |
| DTIL Precision Biosciences Inc. | New | 0.34% | +0.34 |
| ACOG Alpha Cognition Inc. | Add +67.6% | 0.77% | +0.25 |
| TRDA Entrada Therapeutics Inc. | New | 0.24% | +0.24 |
| TNYA Tenaya Therapeutics Inc. | New | 0.22% | +0.22 |
| AMD Advanced Micro Devices | Add +16.6% | 0.81% | +0.21 |
| AVGO Broadcom Inc. | Add +48.8% | 0.71% | +0.19 |
| CAMT Camtek Ltd. | Add +36.0% | 0.88% | +0.15 |
| STTK Shattuck Labs Inc. | New | 0.15% | +0.15 |
| KURA Kura Oncology Inc. | Add +20.4% | 0.64% | +0.13 |
| MDWD Mediwound Ltd. | Add +24.3% | 0.89% | +0.10 |
| PALI Palisade Bio Inc. | New | 0.09% | +0.09 |
| CLDX Celldex Therapeutics Inc. | Add +15.4% | 1.36% | +0.09 |
| PRLD Prelude Therapeutics Inc. | New | 0.07% | +0.07 |
| VYGR Voyager Therapeutics Inc. | Add +70.1% | 0.28% | +0.06 |
| MREO Mereo Biopharma Group PL-ADR | New | 0.02% | +0.02 |
| IBIT iShares Bitcoin Trust ETF | Add +40.1% | 0.31% | −0.02 |
| SNY Sanofi-ADR | Add +9.1% | 2.43% | −0.03 |
| JANX Janux Therapeutics Inc. | Add +83.9% | 0.46% | −0.04 |
| NVMI Nova Ltd. | Add +9.0% | 3.28% | −0.04 |
Options Activity Q3 2025 → Q4 2025
| MRUS Merus NV | call | Sold out | 150,000 | $14.1Mbefore exit |
| PRAX Praxis Precision Medicines I | call | Reduce -20.0% | 40,000 | $11.8M |
| CDTX Cidara Therapeutics Inc. | call | Sold out | 100,000 | $9.6Mbefore exit |
| XBI SS SPDR S&P Biotech ETF | put | New | 70,000 | $8.5M |
| RARE Ultragenyx Pharmaceutical Inc. | call | New | 350,000 | $8.1M |
| BBIO Bridgebio Pharma Inc. | call | Sold out | 130,000 | $6.8Mbefore exit |
| NICE Nice Ltd. - Spon ADR | call | New | 55,700 | $6.3M |
| QURE Uniqure NV | put | Sold out | 75,000 | $4.4Mbefore exit |
| SRPT Sarepta Therapeutics Inc. | call | Sold out | 150,000 | $2.9Mbefore exit |
| TVTX Travere Therapeutics Inc. | call | Sold out | 101,800 | $2.4Mbefore exit |
| ROIV Roivant Sciences Ltd. | call | Sold out | 151,600 | $2.3Mbefore exit |
| GPCR Structure Therapeutics Inc. | call | Sold out | 50,000 | $1.4Mbefore exit |
| TRVI Trevi Therapeutics Inc. | call | Sold out | 129,200 | $1.2Mbefore exit |
| ELDN Eledon Pharmaceuticals Inc. | put | Sold out | 200,000 | $518Kbefore exit |
| MLTX Moonlake Immunotherapeutics | call | Sold out | 10,000 | $72Kbefore exit |
Calls and puts are listed by the shares they cover; their value is not part of the stock holdings above.
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 97 | $698.8M | TEVA, MLYS, TSEM, SNDX, BIIB |
| Q1 2026 | 92 | $581.5M | MLYS, TEVA, TSEM, NVMI, BBIO |
| Q4 2025 | 94 | $478.5M | TEVA, BIIB, MLYS, SNDX, NVMI |
| Q3 2025 | 101 | $421.6M | TEVA, NICE, TSEM, NVMI, QQQ |
| Q2 2025 | 101 | $382.5M | TEVA, NVMI, SNDX, TSEM, CYTK |
| Q1 2025 | 111 | $405.5M | TEVA, SNDX, SNY, NVMI, AZN |
| Q4 2024 | 102 | $541.4M | TEVA, BBIO, SNY, SNDX, AZN |
| Q3 2024 | 107 | $611.0M | TEVA, SNY, BBIO, SNDX, AMZN |
| Q2 2024 | 109 | $613.3M | BBIO, SNY, CYTK, AMZN, SNDX |
| Q1 2024 | 92 | $617.3M | TEVA, SNY, NICE, CYTK, SNDX |